Providence Alaska Medical Center
Anchorage, Alaska, 99508, United States
NCT Number: NCT01215461
The purpose of this study is to better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. As a result, an improved neonatal mortality classification system may be defined.
Looking for future studies?
Notify Me22 week–44 week
All sexes
Observational
Anchorage, Alaska, 99508, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: neonatal outcomes
Pediatrix
Other
Evaluation of Factors Associated With Mortality in Neonates
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00860470
Death, Female Urogenital Diseases and Pregnancy Complications
Baltimore, Maryland, United States
View Trial DetailsNCT03154177
Death, Female Urogenital Diseases and Pregnancy Complications
Kigali, Rwanda
View Trial DetailsNCT00133744
Anemia, Birth Weight
Fengrun, Hebei, China
View Trial DetailsNCT00418353
Female Urogenital Diseases and Pregnancy Complications, Intraventricular Hemorrhage
Stony Brook, New York, United States
View Trial Details